The potent Toxoplasma gondii growth inhibitor QQ-437 does not bind to its predicted target, parasite adaptin3β, in yeast three-hybrid assays
Tran, F.; Foderaro, J. E.; Westwood, N. J.; Ward, G. E.
Show abstract
New drugs are needed to treat infections with Toxoplasma gondii, a ubiquitous protozoan parasite that can cause miscarriage, blindness, and life-threatening encephalitis in its human hosts. A novel N-benzoyl-2-hydroxybenzamide named QQ-437 was recently shown to be a potent inhibitor of T. gondii growth in vitro (EC50 = 16nM), and to reduce parasite load in a mouse model of infection. Intriguingly, mutations in the parasite protein TgAP3{beta}, which is thought to play an important role in intracellular protein trafficking, confer resistance to QQ-437. In this report, we use yeast three-hybrid analysis to test the hypothesis that QQ-437 inhibits parasite growth via a direct effect on TgAP3{beta}. We see no evidence for the ability of QQ-437 to bind directly to TgAP3{beta}, suggesting that the mutation in TgAP3{beta} that confers resistance does so through an indirect mechanism. Further studies are needed to identify the direct molecular target(s) of this promising class of compounds.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Discovery and characterization of a chemical probe targeting the zinc-finger ubiquitin-binding domain of HDAC6 96%
- Development of a chemical probe to enable characterization of the casein kinase 1γ subfamily 96%
- Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 96%
Similar papers in this journal
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 97%
- Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators 97%
- Shifting the selectivity of pyridopyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily 96%
Similar papers in this journal
- Identification and characterization of a small-molecule inhibitor of the Pseudomonas aeruginosa SOS response 95%
- Legacy 4(1H)-quinolone scaffolds activity against acute and chronic Toxoplasma gondii infection 93%
- Small-Molecule In Vitro Inhibitors of the Coronavirus Spike - ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 93%
Similar papers in this journal
Similar papers in this journal
- Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents 96%
- Antibacterial, antibiofilm and anti-quorum sensing activities of 1,2,3,5-tetrazine derivatives linked to a benzothiazole moiety 96%
- Exploring novel fluorine rich fuberidazole derivatives as hypoxic cancer inhibitors: design, synthesis, pharmacokinetics, molecular docking and DFT evaluations 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.